Decoy Therapeutics Inc. Common Stock (DCOY) Stock Price

DCOYStock

$2.98−95.51%52W

Market Cap$1.95M

P/E—

PEG Ratio—

Div yield—

Beta0.61

DCOY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-77.15%

Price vs S&P 500 (4W)-26.07%

VGM Score6.58

Book Value / Share (Quarterly)$87.47

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-147.41

Price vs S&P 500 (YTD)-72.04%

Gross Margin (TTM)48.62%

Net Profit Margin (TTM)-179.05%

EPS (TTM)$-1011.67

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-1011.67

EPS (Annual)$-5.79

ROI (Annual)-321.56%

Gross Margin (Annual)48.61%

Net Profit Margin (5Y Avg)-1270.39%

Cash / Share (Quarterly)$176.42

ROA (Last FY)-184.45%

EBITD / Share (TTM)$-619.84

ROE (5Y Avg)-195.30%

Operating Margin (TTM)-179.62%

Cash Flow / Share (Annual)$-108.89

P/B Ratio0.53x

P/B Ratio (Quarterly)0.90x

Net Income / Employee (Annual)$-506,900

ROA (TTM)-193.31%

EPS Incl Extra (Annual)$-5.79

Current Ratio (Annual)2.13x

Quick Ratio (Quarterly)1.72x

3-Month Avg Trading Volume0.18M

52-Week Price Return-95.51%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)1.12x

Asset Turnover (Annual)0.05x

52-Week High$75.36

Operating Margin (5Y Avg)-1288.41%

EPS Excl Extra (Annual)$-5.79

26-Week Price Return-65.90%

Quick Ratio (Annual)2.07x

13-Week Price Return-51.63%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.84x

Enterprise Value$-5.75M

Asset Turnover (TTM)0.13x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-693.85%

Cash / Share (Annual)$241.60

3-Month Return Std Dev189.07%

Net Income / Employee (TTM)$-1,184,900

ROE (Last FY)-368.77%

EPS Basic Excl Extra (Annual)$-5.79

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1011.67

Receivables Turnover (Annual)0.00x

ROI (TTM)-258.50%

P/S Ratio (TTM)0.44x

Pretax Margin (5Y Avg)-1270.40%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-113.82%

Year-to-Date Return-60.08%

5-Day Price Return-15.26%

EPS Normalized (Annual)$-5.79

ROA (5Y Avg)-130.27%

Net Profit Margin (Annual)-693.85%

Month-to-Date Return-24.33%

EBITD / Share (Annual)$-5.96

Operating Margin (Annual)-696.28%

ROI (5Y Avg)-183.25%

EPS Basic Excl Extra (TTM)$-1011.67

P/B Ratio (Annual)0.71x

Inventory Turnover (TTM)1.39x

Pretax Margin (TTM)-179.05%

Book Value / Share (Annual)$132.84

Price vs S&P 500 (13W)-54.43%

Beta0.61x

Revenue / Share (TTM)$0.00

ROE (TTM)-258.50%

52-Week Low$3.07

mGradeF

vgmGradeF

DCOY Earnings Surprise History

Q3 25-21.72est. —

Q4 2543.10est. -6.48

Q1 26-4.18est. -4.08

DCOY Analyst Recommendations

Oct 2024

Nov 2024

Dec 2024

Jan 2025

2.17

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
DCOYDecoy Therapeutics Inc. Common Stock	—	—	F	$2.98
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics is a preclinical-stage biotechnology company developing peptide conjugate therapeutics for respiratory viruses and gastrointestinal cancers. The company combines machine learning and artificial intelligence with high-throughput synthesis to accelerate drug discovery and candidate optimization.